(Q24803259)

6 July 2017

1 reference

24 August 2020

Future possibilities in the prevention of breast cancer: breast cancer prevention trials (English)

1 reference

estrogen receptor modulators

6 July 2017

1 reference

7 November 2019

1 reference

24 August 2020

1 reference

17 November 2019

1 reference

24 August 2020

raloxifene hydrochloride

1 reference

1 reference

J Cuzick

1

1 reference

PubMed ID

11250718

6 July 2017

language of work or name

English

0 references

publication date

19 May 2000

7 references

6 July 2017

13 March 2019

3 April 2019

17 June 2019

7 November 2019

17 November 2019

24 August 2020

Breast Cancer Research

7 references

6 July 2017

13 March 2019

3 April 2019

17 June 2019

7 November 2019

17 November 2019

24 August 2020

2

1 reference

6 July 2017

4

1 reference

6 July 2017

258-263

1 reference

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

6 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

7 April 2017

1 reference

Crossref

https://api.crossref.org/works/10.1186/BCR66

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Induction of covalent DNA adducts in rodents by tamoxifen.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=138785

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR66

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR66

21 January 2018

1 reference

12 December 2020

The prevention of breast cancer

1 reference

12 December 2020

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

12 December 2020

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Tamoxifen and contralateral breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR66

1 reference

PubMed ID

11250718

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference

PubMed ID

11250718